Genesis MedTech Group has enlisted the assistance of Citic Securities, Goldman Sachs Group, and Morgan Stanley, for a projected initial public offering in Hong Kong, which may occur next year. The medical device firm has the potential to raise up to US$500 million in the IPO, depending on market conditions.